Literature DB >> 19109315

Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials.

L A C Machado1, S J Kamper, R D Herbert, C G Maher, J H McAuley.   

Abstract

OBJECTIVE: Estimates of treatment effects reported in placebo-controlled randomized trials are less subject to bias than those estimates provided by other study designs. The objective of this meta-analysis was to estimate the analgesic effects of treatments for non-specific low back pain reported in placebo-controlled randomized trials.
METHODS: Medline, Embase, Cinahl, PsychInfo and Cochrane Central Register of Controlled Trials databases were searched for eligible trials from earliest records to November 2006. Continuous pain outcomes were converted to a common 0-100 scale and pooled using a random effects model.
RESULTS: A total of 76 trials reporting on 34 treatments were included. Fifty percent of the investigated treatments had statistically significant effects, but for most the effects were small or moderate: 47% had point estimates of effects of <10 points on the 100-point scale, 38% had point estimates from 10 to 20 points and 15% had point estimates of >20 points. Treatments reported to have large effects (>20 points) had been investigated only in a single trial.
CONCLUSIONS: This meta-analysis revealed that the analgesic effects of many treatments for non-specific low back pain are small and that they do not differ in populations with acute or chronic symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109315     DOI: 10.1093/rheumatology/ken470

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  59 in total

1.  Responsiveness of the 24-, 18- and 11-item versions of the Roland Morris Disability Questionnaire.

Authors:  Luciana Gazzi Macedo; Chris G Maher; Jane Latimer; Mark J Hancock; Luciana A C Machado; James H McAuley
Journal:  Eur Spine J       Date:  2010-10-31       Impact factor: 3.134

Review 2.  Cyclobenzaprine for acute back pain.

Authors:  Emélie Braschi; Scott Garrison; G Michael Allan
Journal:  Can Fam Physician       Date:  2015-12       Impact factor: 3.275

Review 3.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

4.  Erratum to: Prevalence of sleep disturbance in patients with low back pain.

Authors:  Saad M Alsaadi; James H McAuley; Julia M Hush; Chris G Maher
Journal:  Eur Spine J       Date:  2012-03       Impact factor: 3.134

5.  The patient-specific functional scale is more responsive than the Roland Morris disability questionnaire when activity limitation is low.

Authors:  Amanda M Hall; Chris G Maher; Jane Latimer; Manuela L Ferreira; Leonardo O P Costa
Journal:  Eur Spine J       Date:  2010-07-14       Impact factor: 3.134

Review 6.  Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain.

Authors:  Hélène Cawston; Alison Davie; Marie-Ange Paget; Vladimir Skljarevski; Michael Happich
Journal:  Eur Spine J       Date:  2013-05-18       Impact factor: 3.134

7.  Pain: continued uncertainty of TENS' effectiveness for pain relief.

Authors:  Mark I Johnson; Deirdre M Walsh
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

8.  [Chronic lower back pain].

Authors:  A Werber; M Schiltenwolf
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

9.  N-of-1 Randomized Trials of Ultra-Micronized Palmitoylethanolamide in Older Patients with Chronic Pain.

Authors:  Federico Germini; Anna Coerezza; Luca Andreinetti; Alessandro Nobili; Paolo Dionigi Rossi; Daniela Mari; Gordon Guyatt; Maura Marcucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

10.  The effectiveness of the McKenzie method in addition to first-line care for acute low back pain: a randomized controlled trial.

Authors:  Luciana A C Machado; Chris G Maher; Rob D Herbert; Helen Clare; James H McAuley
Journal:  BMC Med       Date:  2010-01-26       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.